Monday, 24 April 2017
Last updated 2 days ago
Aug 9 2007 | 1:09pm ET
Stamford, Conn.-based Galen Partners, a healthcare private equity firm, recently raised $250 million for its fifth fund, which will invest in healthcare information technology/outsourcing, medical devices and specialty pharmaceutical companies.
Galen Partners V seeks opportunities to invest between $10 million to $30 million per deal.
“Since our founding in 1990, Galen has pursued a differentiated investment strategy that has proven to be a formula for generating superior, risk-adjusted returns in healthcare private equity,” stated David Jahns, managing director and partner of Galen. “The strategy has evolved over time to reflect Galen’s investment experience and to capitalize on emerging trends in healthcare, but also to maintain a commitment to the fundamental, proven principles on which Galen was founded.”
With nearly $1 billion under management raised through five funds, Galen has invested in more than 60 companies since 1990.